Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026)
Delcath Systems' (DCTH) quarterly Cash from Investing Activities came in at -$571000.0 in Q1 2026, up 97.73% year-on-year from -$288778.4 in Q1 2025, and down 1.78% quarter-over-quarter from -$561000.0 in Q4 2025.
Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Delcath Systems' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$571000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 97.73% year-over-year to -$571000.0 in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 93.46% increase from a year earlier, with the FY2025 full-year figure at -$26.6 million, down 2610.5% from the prior year.
- Cash from Investing Activities retreated to -$571000.0 in Q1 2026 per DCTH's latest filing, from -$561000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $10.3 million in Q2 2024 and bottomed at -$25.1 million in Q1 2025.
- The 5-year median for Cash from Investing Activities is -$415000.0 (2025), against an average of -$3.2 million.
- Biggest YoY gain for Cash from Investing Activities was 25810.0% in 2024; the steepest drop was 69800.0% in 2024.
- Year by year, Cash from Investing Activities stood at -$68000.0 in 2022, then sank by 28826.47% to -$19.7 million in 2023, then grew by 22.58% to -$15.2 million in 2024, then jumped by 96.32% to -$561000.0 in 2025, then fell by 1.78% to -$571000.0 in 2026.
- Per Business Quant, the three latest DCTH Cash from Investing Activities figures stand at -$571000.0 (Q1 2026), -$561000.0 (Q4 2025), and -$466000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Delcath Systems | 432.25 Mn | 342.96 Mn | 21.26 Mn | -571,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -571,000.00 |
| Mar 31, 2026 | -571,000.00 |
| Dec 31, 2025 | -561,000.00 |
| Dec 31, 2025 | -561,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | -415,000.00 |
| Jun 30, 2025 | -415,000.00 |
| Mar 31, 2025 | -25.15 Mn |
| Mar 31, 2025 | -25.15 Mn |
| Dec 31, 2024 | -15.23 Mn |
| Dec 31, 2024 | -15.23 Mn |
| Sep 30, 2024 | -697,000.00 |
| Sep 30, 2024 | -697,000.00 |
| Jun 30, 2024 | 10.28 Mn |
| Jun 30, 2024 | 10.28 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | -19.67 Mn |
| Dec 31, 2023 | -19.67 Mn |